Literature DB >> 21053002

[Cytologic diagnosis of sarcoma].

B Bode-Lesniewska1.   

Abstract

Soft tissue swelling represents a common clinical sign of a variety of neoplastic and non-neoplastic lesions. Sarcoma is rarely a cause. Fine needle biopsy as a minimally invasive, economic and accurate method is well suited for the diagnosis of inflammatory/infectious processes as well as of recurrent and metastatic disease. Cytologic diagnosis of primary soft tissue tumors is also feasible. It requires close collaboration with other medical disciplines and incorporation of clinical, radiological and morphologic findings. Clinical data such as age, gender, size and topography are important parameters. The differentiation of cells and properties of the extracellular matrix supplies clues for the differential diagnosis and forms the starting point for immunohistochemical or molecular analysis (FISH, RT-PCR). This analysis may be performed on cytological smears, paraffin embedded material of the cell blocks or on frozen material.

Entities:  

Mesh:

Year:  2011        PMID: 21053002     DOI: 10.1007/s00292-010-1396-9

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  29 in total

1.  Liquid-based vs. conventional smears in fine needle aspiration of bone and soft tissue tumors.

Authors:  Kasturi Das; Meera Hameed; Debra Heller; Neena Mirani; Nancy Doty; Joseph Benevenia; Francis Patterson; Seena Aisner
Journal:  Acta Cytol       Date:  2003 Mar-Apr       Impact factor: 2.319

2.  Fine needle aspiration cytology of pseudosarcomatous reactive proliferative lesions of soft tissue.

Authors:  Nim Lai Wong
Journal:  Acta Cytol       Date:  2002 Nov-Dec       Impact factor: 2.319

3.  Fine-needle aspiration of primary osseous lesions: A cost effectiveness study.

Authors:  Lester J Layfield; Leslie G Dodd; Sharon Hirschowitz; Susie Newman Crabtree
Journal:  Diagn Cytopathol       Date:  2010-04       Impact factor: 1.582

Review 4.  Fine-needle aspiration cytology of pseudosarcomatous lesions of soft tissue.

Authors:  L G Dodd; S Martinez
Journal:  Diagn Cytopathol       Date:  2001-01       Impact factor: 1.582

5.  Reverse transcriptase-polymerase chain reaction as an ancillary molecular technique in the diagnosis of small blue round cell tumors by fine-needle aspiration cytology.

Authors:  Upasana Gautam; Radhika Srinivasan; Arvind Rajwanshi; Deepak Bansal; Ram Kumar Marwaha; Rakesh Kumar Vasishtha
Journal:  Am J Clin Pathol       Date:  2010-04       Impact factor: 2.493

6.  Soft tissue aspiration cytopathology.

Authors:  P E Wakely; J S Kneisl
Journal:  Cancer       Date:  2000-10-25       Impact factor: 6.860

7.  Cytohistologic correlations of 24 malignant peripheral nerve sheath tumor (MPNST) in 17 patients: the Institut Curie experience.

Authors:  Jerzy Klijanienko; Jean-Michel Caillaud; Réal Lagacé; Philippe Vielh
Journal:  Diagn Cytopathol       Date:  2002-08       Impact factor: 1.582

8.  Fine-needle aspiration in myxofibrosarcoma: experience of Institut Curie.

Authors:  Pierre Colin; Réal Lagacé; Jean-Michel Caillaud; Xavier Sastre-Garau; Jerzy Klijanienko
Journal:  Diagn Cytopathol       Date:  2010-05       Impact factor: 1.582

9.  Low-grade fibromyxoid sarcoma is difficult to diagnose by fine needle aspiration cytology: a cytomorphological study of eight cases.

Authors:  H A Domanski; F Mertens; I Panagopoulos; M Akerman
Journal:  Cytopathology       Date:  2008-07-14       Impact factor: 2.073

10.  Grading of soft tissue sarcomas on fine-needle aspiration cytology smear.

Authors:  Mrinmay Kumar Mallik; Pranab Dey; Subhash Kumari Gupta; Rakesh Kumar Vasishta
Journal:  Diagn Cytopathol       Date:  2010-02       Impact factor: 1.582

View more
  2 in total

1.  [A plea for cytopathology].

Authors:  P Dalquen
Journal:  Pathologe       Date:  2012-07       Impact factor: 1.011

2.  [Open biopsy of bone and soft tissue tumors : guidelines for precise surgical procedures].

Authors:  B M Holzapfel; M Lüdemann; D E Holzapfel; H Rechl; M Rudert
Journal:  Oper Orthop Traumatol       Date:  2012-09       Impact factor: 1.154

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.